ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AMAM Ambrx Biopharma Inc

28.00
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Ambrx Biopharma Inc AMAM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 28.00 10:00:00
Open Price Low Price High Price Close Price Previous Close
28.00
more quote information »

Recent News

Date Time Source Heading
19/3/202405:45EDGAR2Form 15-12G - Securities registration termination [Section..
13/3/202407:55EDGAR2Form 8-K - Current report
11/3/202415:15EDGAR2Form EFFECT - Notice of Effectiveness
09/3/202405:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
08/3/202405:23EDGAR2Form POS AM - Post-Effective amendments for registration..
08/3/202400:49EDGAR2Form 8-K - Current report
07/3/202408:05EDGAR2Form 8-K - Current report
24/2/202406:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/2/202400:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/2/202400:30EDGAR2Form 8-K - Current report
13/2/202405:43PRNUSKuehn Law Encourages AMAM, DOOR, CBAY, and WISH Investors to..
11/1/202407:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
09/1/202406:54DJNTrending: Johnson & Johnson and Merck & Co. Announce..
09/1/202402:04DJNAmbrx Biopharma Shares Double on $2 Billion Acquisition by..
09/1/202400:12DJNJohnson & Johnson to Acquire Cancer-Treatment Developer..
24/10/202308:19EDGAR2Form 15-12G - Securities registration termination [Section..
16/9/202306:27EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
16/9/202306:24EDGAR2Form 8-K - Current report
07/9/202306:05EDGAR2Form 8-K - Current report
26/8/202307:23EDGAR2Form 8-K - Current report
19/7/202323:49DJNAmbrx Biopharma Gets Fast Track Designation for ARX517..
29/6/202306:45EDGAR2Form SC 13D/A - General statement of acquisition of..
29/6/202306:06EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock